By Cara Salvatore ( August 14, 2014, 1:30 PM EDT) -- A Georgia federal judge is refusing to dismiss a shareholder class action against MiMedx Group Inc. over statements that its scar-minimizing injectables weren't subject to normal FDA regulation, saying Wednesday that a full stock-price rebound doesn't necessarily mean the plaintiffs can't show they experienced losses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.